Among its downstream pathways, TGF-β1/Smad2.3 signaling is strongly implicated in EMT and EndMT, which play key roles in COPD-associated airway-vessel remodeling [15, 28, 30]. The gene discussed is SMAD2; the disease is chronic obstructive pulmonary disease.